CymitQuimica logo

Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether

CAS:

Ref. 3D-FL146829

10g
Discontinued
25g
Discontinued
50g
Discontinued
100g
Discontinued
250g
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Biosynth

Product Information

Name:Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Synonyms:
  • 1,1,1,3,3,3-Hexamethyldisilazane lithium saltLithium bis(trimethylsilyl)amide
Brand:Biosynth
Description:Lithium hexamethyl disilazide solution is an inhibitor drug that blocks the synthesis of pyrimidine compounds. It has been shown to be effective in congestive heart failure, hyperproliferative diseases such as pancreatitis and dyslipoproteinemia, coronary heart diseases, and HIV infection. Lithium hexamethyl disilazide solution binds to the cb2 receptor on the surface of activated T cells, which inhibits their ability to cause inflammation or autoimmune disease. This drug also has nitrogen atoms that are reactive and asymmetric, making it a good candidate for an inhibitor drug.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:167.33 g/mol
Formula:C6H18LiNSi2
Purity:Min. 95%

Inquiry about discontinued product: Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.